Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment (original) (raw)

Journal Article

,

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Correspondence to: Mirjana Urosevic, MD, Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland (e-mail: Mirjana.Urosevic@usz.ch ) or Reinhard Dummer, MD, Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland (e-mail: Reinhard.Dummer@usz.ch ).

Search for other works by this author on:

,

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Search for other works by this author on:

,

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Search for other works by this author on:

,

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Search for other works by this author on:

,

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Search for other works by this author on:

,

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Search for other works by this author on:

Affiliation of authors: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Search for other works by this author on:

Received:

08 December 2004

Revision received:

23 May 2005

Published:

03 August 2005

Cite

Mirjana Urosevic, Reinhard Dummer, Curdin Conrad, Mirjam Beyeler, Elisabeth Laine, Günter Burg, Michel Gilliet, Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment, JNCI: Journal of the National Cancer Institute, Volume 97, Issue 15, 3 August 2005, Pages 1143–1153, https://doi.org/10.1093/jnci/dji207
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Background: Imiquimod, an immune response modifier that is used topically to treat different types of skin cancer, induces the production of proinflammatory cytokines that stimulate an antitumor immune response. We assessed characteristics of the imiquimod-induced immune activation in epithelial and lymphoproliferative neoplasias of human skin. We focused on plasmacytoid predendritic cells (PDCs), the primary producer of interferon α (IFN-α) after imiquimod activation in vitro. Methods: We used Affymetrix oligonucleotide arrays to compare gene expression profiles from tumors from 16 patients, 10 with superficial basal cell carcinomas (sBCCs), five with cutaneous T-cell lymphomas (CTCLs), and one with Bowen's disease, before and after topical imiquimod treatment. We used quantitative immunohistochemistry with PDC-specific antibodies against BDCA-2 and CD123 to characterize the PDC population before and after imiquimod treatment in these specimens. Activation status of PDCs from four sBCC patients was assessed by intracellular IFN-α staining and flow cytometry. Results: Expression of various IFN-α–inducible genes (e.g., CIG5, G1P2, OASL, IFIT1, STAT1, IFI35, OAS1, ISG20, MxA, and IRF7), the so-called IFN-α signature, was increased similarly in both sBCC and CTCL lesions after imiquimod treatment. PDCs were recruited and activated in both lesion types, and they produced IFN-α after imiquimod treatment in vivo (mean percentage of PDCs producing IFN-α = 14.5%, 95% confidence interval [CI] = 4.9% to 24%; range = 3.3%–27%, n = 4 lesions). Imiquimod induced similar immune activation patterns in all three diseases, and these patterns were associated with the number of PDCs recruited to the treatment site. Two imiquimod-treated sBCC patients who did not mount an inflammatory response to imiquimod and whose lesions lacked the IFN-α signature after treatment had fewer PDCs in treated lesions compared with other treated patients with such a response. Conclusions: Imiquimod induces immune activation patterns that relate to the number of the PDCs recruited to the treatment site, thus supporting the role of PDC in responsiveness to imiquimod in humans.

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org.

Topic:

You do not currently have access to this article.

Personal account

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

  1. Click Sign in through your institution.
  2. Select your institution from the list provided, which will take you to your institution's website to sign in.
  3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
  4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

  1. Click Sign in through society site.
  2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
  3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment - 24 Hours access

EUR €38.00

GBP £33.00

USD $41.00

Rental

Read this now at DeepDyve

This article is also available for rental through DeepDyve.

Citations

Views

Altmetric

Metrics

Total Views 2,147

1,447 Pageviews

700 PDF Downloads

Since 11/1/2016

Month: Total Views:
November 2016 2
December 2016 1
January 2017 2
February 2017 8
March 2017 9
April 2017 10
May 2017 4
June 2017 10
July 2017 7
August 2017 7
September 2017 7
October 2017 7
November 2017 7
December 2017 30
January 2018 21
February 2018 20
March 2018 34
April 2018 29
May 2018 31
June 2018 35
July 2018 24
August 2018 16
September 2018 22
October 2018 31
November 2018 35
December 2018 30
January 2019 22
February 2019 29
March 2019 30
April 2019 45
May 2019 24
June 2019 27
July 2019 37
August 2019 39
September 2019 18
October 2019 72
November 2019 40
December 2019 23
January 2020 11
February 2020 24
March 2020 73
April 2020 24
May 2020 23
June 2020 15
July 2020 12
August 2020 19
September 2020 32
October 2020 18
November 2020 13
December 2020 17
January 2021 33
February 2021 11
March 2021 61
April 2021 21
May 2021 21
June 2021 17
July 2021 14
August 2021 21
September 2021 17
October 2021 13
November 2021 30
December 2021 18
January 2022 24
February 2022 16
March 2022 17
April 2022 11
May 2022 18
June 2022 26
July 2022 20
August 2022 20
September 2022 18
October 2022 40
November 2022 27
December 2022 27
January 2023 13
February 2023 21
March 2023 22
April 2023 29
May 2023 41
June 2023 13
July 2023 15
August 2023 17
September 2023 17
October 2023 17
November 2023 34
December 2023 22
January 2024 12
February 2024 25
March 2024 29
April 2024 21
May 2024 32
June 2024 14
July 2024 41
August 2024 24
September 2024 17
October 2024 4

Citations

158 Web of Science

×

Email alerts

Citing articles via

More from Oxford Academic